EVE Health (Australia) Performance
| EVE Stock | 0 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and EVE Health are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days EVE Health Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, EVE Health is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Last Split Factor 6:5 | Last Split Date 2022-06-01 |
1 | Trump Media stock closes at new postmerger low on eve of lockup expiration - CNBC | 09/18/2024 |
2 | Doctors say patients want them, not physician associates, to lead health care AMA - Medical Economics | 09/27/2024 |
3 | Ep 42 Patient management challenges with Eve Cunningham, MD, of Providence - Medical Economics | 10/21/2024 |
4 | Shares of Donald Trumps social media firm surge on eve of the US Election Day - CNBCTV18 | 11/05/2024 |
| Begin Period Cash Flow | 192.5 K |
EVE |
EVE Health Relative Risk vs. Return Landscape
If you would invest 0.10 in EVE Health Group on August 29, 2024 and sell it today you would earn a total of 0.00 from holding EVE Health Group or generate 0.0% return on investment over 90 days. EVE Health Group is producing return of less than zero assuming 0.0% volatility of returns over the 90 days investment horizon. Simply put, 0% of all stocks have less volatile historical return distribution than EVE Health, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
EVE Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EVE Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EVE Health Group, and traders can use it to determine the average amount a EVE Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EVE |
Based on monthly moving average EVE Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EVE Health by adding EVE Health to a well-diversified portfolio.
EVE Health Fundamentals Growth
EVE Stock prices reflect investors' perceptions of the future prospects and financial health of EVE Health, and EVE Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EVE Stock performance.
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.3 | ||||
| Profit Margin | (0.89) % | ||||
| Operating Margin | (0.75) % | ||||
| Current Valuation | 5.24 M | ||||
| Shares Outstanding | 5.27 B | ||||
| Price To Book | 4.31 X | ||||
| Price To Sales | 2.47 X | ||||
| Revenue | 2.13 M | ||||
| Gross Profit | 827.83 K | ||||
| EBITDA | (1.51 M) | ||||
| Net Income | (1.55 M) | ||||
| Cash And Equivalents | 1.1 M | ||||
| Total Debt | 74.85 K | ||||
| Cash Flow From Operations | (1.11 M) | ||||
| Total Asset | 2.52 M | ||||
| Retained Earnings | (34.8 M) | ||||
About EVE Health Performance
Assessing EVE Health's fundamental ratios provides investors with valuable insights into EVE Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the EVE Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
EVE Health is entity of Australia. It is traded as Stock on AU exchange.Things to note about EVE Health Group performance evaluation
Checking the ongoing alerts about EVE Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EVE Health Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EVE Health Group generated a negative expected return over the last 90 days | |
| EVE Health Group has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.13 M. Net Loss for the year was (1.55 M) with profit before overhead, payroll, taxes, and interest of 827.83 K. | |
| EVE Health Group has accumulated about 1.1 M in cash with (1.11 M) of positive cash flow from operations. | |
| Roughly 51.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Shares of Donald Trumps social media firm surge on eve of the US Election Day - CNBCTV18 |
- Analyzing EVE Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EVE Health's stock is overvalued or undervalued compared to its peers.
- Examining EVE Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EVE Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EVE Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EVE Health's stock. These opinions can provide insight into EVE Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for EVE Stock Analysis
When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.